Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-09-06

Clinical Trial Update: Rosiglitazone and Insulin in T1DM Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating rosiglitazone in combination with insulin in adolescents with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • Rosiglitazone (rosiglitazone)

Snippet

Sponsor: The University of New South Wales | Conditions: Type 1 Diabetes, Puberty: >Tanner 2 Breast Development or Testis >4ml | Phase 4 | Status: COMPLETED